Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

37.35 -0.47 (-1.24%)
Streaming Delayed Price Updated: 9:56 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call
Omnicell’s fourth quarter was met with a significant negative market reaction, as the company delivered revenue in line with Wall Street expectations but posted a notable shortfall in non-GAAP... 
Via StockStory
Topics Earnings
News headline image
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook
Healthcare tech company Omnicell (NASDAQ:OMCL) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 2.3% year on year to $314 million. The company expects next quarter’s revenue to be... 
Via StockStory
Topics World Trade
News headline image
Why Omnicell (OMCL) Shares Are Plunging Today
Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 18.4% in the morning session after the company reported fourth-quarter earnings that fell short of Wall Street expectations and provided a... 
Via StockStory
Topics Artificial Intelligence
Omnicell Inc (NASDAQ:OMCL) Stock Plummets on Earnings Miss and Soft 2026 Guidance ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
Omnicell (OMCL) Q4 2025 Earnings Call Transcript ↗
Omnicell (OMCL) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 2.3% year on year to $314 million. The company expects next quarter’s revenue to be... 
Via StockStory
News headline image
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Earnings: What To Look For From OMCL
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Omnicell (NASDAQ:OMCL) and... 
Via StockStory
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but... 
Via StockStory
Topics Stocks
News headline image
3 Russell 2000 Stocks We Approach with Caution
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
3 Reasons to Sell OMCL and 1 Stock to Buy Instead
The past six months have been a windfall for Omnicell’s shareholders. The company’s stock price has jumped 80.2%, hitting $50.52 per share. This was partly thanks to its solid quarterly results, and... 
Via StockStory
News headline image
3 Small-Cap Stocks We Keep Off Our Radar
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
From Omnicell, Inc.
Via Business Wire
News headline image
3 Inflated Stocks with Open Questions
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant... 
Via StockStory
News headline image
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs ↗
The stock has rallied significantly from its 52-week low of $22.66 in May. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management
From Omnicell, Inc.
Via Business Wire
News headline image
1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the... 
Via StockStory
Topics Stocks
News headline image
Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show
From Omnicell, Inc.
Via Business Wire
News headline image
Healthcare Technology for Providers Q3 Earnings: Privia Health (NASDAQ:PRVA) is the Best in the Biz
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Privia Health (NASDAQ:PRVA) and its peers. 
Via StockStory
News headline image
3 Low-Volatility Stocks That Concern Us
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies
From Omnicell, Inc.
Via Business Wire
News headline image
3 Russell 2000 Stocks with Warning Signs
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
News headline image
Why Omnicell Stock Crushed the Market Today ↗
The company continues to benefit from demand for its next-generation healthcare tech offerings. 
Via The Motley Fool
News headline image
Why Omnicell (OMCL) Stock Is Trading Up Today
Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 10.9% in the morning session after the company reported strong third-quarter 2025 financial results that beat expectations and raised its... 
Via StockStory
Topics Economy Government World Trade
News headline image
Omnicell Inc (NASDAQ:OMCL) Surpasses Q3 2025 Estimates, Stock Rises on Strong Guidance ↗
Omnicell (OMCL) Q3 2025 earnings beat estimates, with revenue of $310.6M and non-GAAP EPS of $0.51. The stock rose 8% pre-market on the strong results and raised guidance. 
Via Chartmill
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.